AMH
ETON icon

Apollo Management Holdings’s Eton Pharmaceutcials ETON Stock Holding History

Apollo Management Holdings’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-90,000
Closed -$720K – 69
2019
Q1 		$720K Hold
90,000
– – 0.01% 72
2018
Q4 		$551K Buy
+90,000
New +$552K 0.01% 77

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Apollo Management Holdings's ETON Position: Q2 2019 in Review

Apollo Management Holdings sold out of Eton Pharmaceutcials (ETON) in Q2 2019, closing a stake of 90,000 shares — an estimated $720K sold.

Apollo Management Holdings first reported a position in ETON in Q4 2018 and held it in 2 quarters. The position peaked at $720K in Q1 2019. 10 funds tracked by Wall St. Rank hold ETON as of Q2 2019.

  • Apollo Management Holdings reported no remaining Eton Pharmaceutcials position as of Q2 2019 after selling out during the quarter.
  • Apollo Management Holdings sold 90,000 Eton Pharmaceutcials shares in Q2 2019, an estimated $720K.
  • Apollo Management Holdings first reported a position in Eton Pharmaceutcials in Q4 2018 and held it in 2 quarters.
  • Apollo Management Holdings's Eton Pharmaceutcials position peaked at $720K in Q1 2019.
  • 10 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2019.

Based on Apollo Management Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.